LifeMD, Inc. (LFMDP) stock
LFMDPNasdaqServices-Offices & Clinics of Doctors of MedicineFiscal year ends December 31Also trades as LFMD
Financials through Q2 FY2026, quarter ended Jun 30, 2026Last filing: 10-Q on Aug 5, 2026Score 10/3099% above fair value
$21.65+0.13 (+0.60%)
Close on Oct 30, 2026Market cap $110.38MP/E –Yield –
LifeMD net income
Net income is the profit left for shareholders after every expense, interest and tax.
LifeMD's net income for the twelve months ending Jun 30, 2026 was $201.01K. For fiscal 2025 it was $14.35M. The highest annual figure on record is $14.35M in fiscal 2025.
Annual net income
| Period | Period end | Value | Change |
|---|---|---|---|
| FY2025 | Dec 31, 2025 | $14.35M | – |
| FY2024 | Dec 31, 2024 | -$21.41M | – |
| FY2023 | Dec 31, 2023 | -$20.60M | – |
| FY2022 | Dec 31, 2022 | -$45.54M | – |
| FY2021 | Dec 31, 2021 | -$60.90M | – |
| FY2020 | Dec 31, 2020 | -$58.65M | – |
| FY2019 | Dec 31, 2019 | -$3.14M | – |
| FY2018 | Dec 31, 2018 | -$1.24M | – |
| FY2017 | Dec 31, 2017 | -$1.21M | – |
| FY2016 | Dec 31, 2016 | -$1.11M | – |
| FY2015 | Dec 31, 2015 | -$61.99K | – |
| FY2014 | Dec 31, 2014 | -$460.49K | – |
| FY2013 | Dec 31, 2013 | -$268.26K | – |
| FY2012 | Dec 31, 2012 | -$445.65K | – |
Quarterly net income
Change is against the same quarter a year earlier.
| Period | Period end | Value | Change |
|---|---|---|---|
| Q2 FY2026 | Jun 30, 2026 | -$7.08M | – |
| Q1 FY2026 | Mar 31, 2026 | -$8.87M | – |
| Q4 FY2025 | Dec 31, 2025 | $19.96M | – |
| Q3 FY2025 | Sep 30, 2025 | -$3.81M | – |
| Q2 FY2025 | Jun 30, 2025 | -$1.62M | – |
| Q1 FY2025 | Mar 31, 2025 | -$183.78K | – |
| Q4 FY2024 | Dec 31, 2024 | -$4.94M | – |
| Q3 FY2024 | Sep 30, 2024 | -$4.66M | – |
| Q2 FY2024 | Jun 30, 2024 | -$6.88M | – |
| Q1 FY2024 | Mar 31, 2024 | -$6.77M | – |
| Q4 FY2023 | Dec 31, 2023 | -$3.73M | – |
| Q3 FY2023 | Sep 30, 2023 | -$6.12M | – |
| Q2 FY2023 | Jun 30, 2023 | -$6.73M | – |
| Q1 FY2023 | Mar 31, 2023 | -$4.01M | – |
| Q4 FY2022 | Dec 31, 2022 | -$11.94M | – |
| Q3 FY2022 | Sep 30, 2022 | -$7.28M | – |
| Q2 FY2022 | Jun 30, 2022 | -$13.02M | – |
| Q1 FY2022 | Mar 31, 2022 | -$13.30M | – |
| Q4 FY2021 | Dec 31, 2021 | -$18.11M | – |
| Q3 FY2021 | Sep 30, 2021 | -$14.35M | – |
| Q2 FY2021 | Jun 30, 2021 | -$16.83M | – |
| Q1 FY2021 | Mar 31, 2021 | -$11.60M | – |
| Q4 FY2020 | Dec 31, 2020 | -$32.25M | – |
| Q3 FY2020 | Sep 30, 2020 | -$20.62M | – |
| Q2 FY2020 | Jun 30, 2020 | -$3.38M | – |
| Q1 FY2020 | Mar 31, 2020 | -$2.39M | – |
| Q4 FY2019 | Dec 31, 2019 | -$711.55K | – |
| Q3 FY2019 | Sep 30, 2019 | -$943.80K | – |
| Q2 FY2019 | Jun 30, 2019 | -$818.10K | – |
| Q1 FY2019 | Mar 31, 2019 | -$663.75K | -205.8% |
| Q4 FY2018 | Dec 31, 2018 | -$765.09K | – |
| Q3 FY2018 | Sep 30, 2018 | -$495.98K | – |
| Q2 FY2018 | Jun 30, 2018 | -$1.05M | -242.2% |
| Q1 FY2018 | Mar 31, 2018 | $627.28K | – |
| Q4 FY2017 | Dec 31, 2017 | -$219.58K | – |
| Q3 FY2017 | Sep 30, 2017 | -$679.06K | – |
| Q2 FY2017 | Jun 30, 2017 | $737.49K | – |
| Q1 FY2017 | Mar 31, 2017 | -$1.04M | – |
| Q4 FY2016 | Dec 31, 2016 | -$618.87K | – |
| Q3 FY2016 | Sep 30, 2016 | -$226.65K | – |